MedPath

Analysis on individual difference in pharmacokinetics of edoxaban and its metabolites, and investigation on predictive parameters of edoxaban response and adverse effects in Japanese patiens

Not Applicable
Recruiting
Conditions
Atrial fibrillation
Registration Number
JPRN-UMIN000040988
Lead Sponsor
Department of Hospital pharmacy Hamamatsu University School of Medicine
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
All
Target Recruitment
200
Inclusion Criteria

Not provided

Exclusion Criteria

1. Patients discontinuing edoxaban 2. Patients who are judged by physicians as inappropriate for study enrollment

Study & Design

Study Type
Observational
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath